NCT01281072|UnknownPhase 3
Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)
1 other identifier
911-DIAPEP277
Study Type
interventional
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredJan 2011
Brief Summary
Open label study to evaluate long term treatment effect of diapep277.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2011
Completed1 day until next milestone
First Posted
Study publicly available on registry
January 21, 2011
CompletedLast Updated
January 21, 2011
Status Verified
January 1, 2011
First QC Date
January 20, 2011
Last Update Submit
January 20, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
c peptide reserve
Interventions
vaccineOTHER
Eligibility Criteria
Age20 Years - 50 Years
Sexall
Age GroupsAdult (18-64)
You may qualify if:
- \. patient that completed 901 and 910 study.
You may not qualify if:
- \. cpeptide\<0.2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadassah Medical Organizationlead
- DIABETES UNITcollaborator
MeSH Terms
Interventions
Vaccines
Intervention Hierarchy (Ancestors)
Biological ProductsComplex Mixtures
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 20, 2011
First Posted
January 21, 2011
Last Updated
January 21, 2011
Record last verified: 2011-01